QNTM

Quantum Biopharma Class B Subordinate Voting Shares
QNTM

11 hedge funds and large institutions have $516K invested in Quantum Biopharma Class B Subordinate Voting Shares in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

28% less capital invested

Capital invested by funds: $714K → $516K (-$197K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$87K
Puts
$5K
Net Calls
Net Calls Change

Top Buyers

1
+$38.6K
2
+$25.9K
3
+$303

Top Sellers

1
-$38.1K
2
-$28.9K
3
-$14K
4
Citadel Advisors
Citadel Advisors
Florida
-$4.1K
5
Bank of America
Bank of America
North Carolina
-$932
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$287K
2
$118K
3
$66.1K
4
$17K
5
$12K
6
$11.7K
7
$2K
8
$1.15K
9
$883
10
$816
11
$1
12
–
13
–
14
–